Related Experiment Video

Updated: Aug 30, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment

Eva V Varga1, Henry I Yamamura, Marc K Rubenzik

  • 1Department of Pharmacology, The University of Arizona Health Sciences Center, Tucson, AZ 85724, USA.

Life Sciences
|November 11, 2003
PubMed

Insights

Chronic opioid agonist treatment leads to analgesic tolerance by desensitizing inhibitory opioid functions and increasing excitatory signaling. This study explores molecular mechanisms, proposing Raf-1 activation as key to increased cAMP formation upon withdrawal.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Opioid agonists provide analgesia via Gi/o protein-coupled receptors, inhibiting pain neurotransmitter release.
  • Chronic opioid use leads to tolerance, characterized by reduced receptor responsiveness and increased excitatory signaling.
  • Understanding these dual effects is crucial for managing pain and opioid dependence.

Purpose of the Study:

  • To review molecular mechanisms underlying the augmentation of excitatory signaling during chronic opioid agonist treatment.
  • To present experimental data on the functional sensitization of cAMP formation in response to chronic opioid receptor activation.
  • To elucidate the role of specific signaling pathways in opioid-induced adaptive changes.

Main Methods:

  • Review of existing literature on opioid signaling and tolerance.
  • Experimental investigation using a recombinant Chinese hamster ovary cell line expressing the human delta-opioid receptor (hDOR/CHO).
  • Analysis of forskolin-stimulated cAMP formation and its modulation by chronic opioid agonist treatment and withdrawal.

Main Results:

  • Chronic opioid agonist treatment desensitizes inhibitory opioid functions while augmenting stimulatory effects.
  • Experimental data suggest activation of multiple redundant pathways converging on Raf-1 kinase.
  • Raf-1 activation leads to sensitization of adenylyl cyclase VI, causing increased cAMP upon agonist withdrawal.

Conclusions:

  • Chronic opioid agonist treatment induces complex adaptive changes, including enhanced excitatory signaling.
  • The Raf-1/adenylyl cyclase VI pathway is implicated in the rebound increase in cAMP formation after chronic opioid exposure.
  • These findings offer insights into the molecular basis of opioid tolerance and potential therapeutic targets.

More Related Videos

Intracranial Pharmacotherapy and Pain Assays in Rodents02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...